Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease

E. Nagy, John C. Morris, Henry B. Burch, Sudershan Bhatia, Kalman Salata, Kenneth D. Burman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The human TSH receptor represents the primary target of thyroid-stimulating immunoglobulins responsible for the hyperthyroidism of Graves' disease. In the present series of investigations, the distribution of T cell epitopes has been mapped using synthetic peptides spanning the entire extracellular region of the human TSH receptor. In vitro proliferatire responses of the mononuclear cells were measured using flow cytometric analysis of bromodeoxyuridine incorporation into nuclei. In 8 of 11 samples from patients with Graves' disease, at least one (and up to 9) regions of the human TSH receptor induced proliferation, with the mean stimulation index being 39.8 ± 47.3. No single universal stimulatory peptide was identified. In contrast, stimulation was not observed in three control subjects, while one control subject showed minimal stimulation (index of 5.7) to peptides encompassing a limited area (amino acids 31-65). The immunodominant epitope of patients with recent-onset Graves' disease was localized between amino acids 271 and 365, whereas the immunodominant epitope of patients with disease duration greater than 1 year localized between amino acids 91 and 215. We conclude that the bromodeoxyuridine incorporation method is a useful and important tool for detecting antigen-induced lymphocyte proliferation. The TSH receptor-specific T cells from different Graves' disease patients recognize variable distinct sites within the extracellular region of the TSH receptor, and the immunodominant epitope apparently shifts toward the N-terminus of the receptor protein during the course of treated Graves' disease.

Original languageEnglish
Pages (from-to)117-124
Number of pages8
JournalClinical Immunology and Immunopathology
Volume75
Issue number2
DOIs
Publication statusPublished - May 1995

Fingerprint

Thyrotropin Receptors
T-Lymphocyte Epitopes
Graves Disease
Thyroid Diseases
Autoimmune Diseases
Immunodominant Epitopes
Bromodeoxyuridine
Amino Acids
Peptides
Thyroid-Stimulating Immunoglobulins
Hyperthyroidism
Lymphocytes
T-Lymphocytes
Antigens
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Immunology and Allergy
  • Immunology

Cite this

Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease. / Nagy, E.; Morris, John C.; Burch, Henry B.; Bhatia, Sudershan; Salata, Kalman; Burman, Kenneth D.

In: Clinical Immunology and Immunopathology, Vol. 75, No. 2, 05.1995, p. 117-124.

Research output: Contribution to journalArticle

Nagy, E, Morris, JC, Burch, HB, Bhatia, S, Salata, K & Burman, KD 1995, 'Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease', Clinical Immunology and Immunopathology, vol. 75, no. 2, pp. 117-124. https://doi.org/10.1006/clin.1995.1060
Nagy, E. ; Morris, John C. ; Burch, Henry B. ; Bhatia, Sudershan ; Salata, Kalman ; Burman, Kenneth D. / Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease. In: Clinical Immunology and Immunopathology. 1995 ; Vol. 75, No. 2. pp. 117-124.
@article{8951273d71534d8db1dcde39f3a9ac96,
title = "Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease",
abstract = "The human TSH receptor represents the primary target of thyroid-stimulating immunoglobulins responsible for the hyperthyroidism of Graves' disease. In the present series of investigations, the distribution of T cell epitopes has been mapped using synthetic peptides spanning the entire extracellular region of the human TSH receptor. In vitro proliferatire responses of the mononuclear cells were measured using flow cytometric analysis of bromodeoxyuridine incorporation into nuclei. In 8 of 11 samples from patients with Graves' disease, at least one (and up to 9) regions of the human TSH receptor induced proliferation, with the mean stimulation index being 39.8 ± 47.3. No single universal stimulatory peptide was identified. In contrast, stimulation was not observed in three control subjects, while one control subject showed minimal stimulation (index of 5.7) to peptides encompassing a limited area (amino acids 31-65). The immunodominant epitope of patients with recent-onset Graves' disease was localized between amino acids 271 and 365, whereas the immunodominant epitope of patients with disease duration greater than 1 year localized between amino acids 91 and 215. We conclude that the bromodeoxyuridine incorporation method is a useful and important tool for detecting antigen-induced lymphocyte proliferation. The TSH receptor-specific T cells from different Graves' disease patients recognize variable distinct sites within the extracellular region of the TSH receptor, and the immunodominant epitope apparently shifts toward the N-terminus of the receptor protein during the course of treated Graves' disease.",
author = "E. Nagy and Morris, {John C.} and Burch, {Henry B.} and Sudershan Bhatia and Kalman Salata and Burman, {Kenneth D.}",
year = "1995",
month = "5",
doi = "10.1006/clin.1995.1060",
language = "English",
volume = "75",
pages = "117--124",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Thyrotropin Receptor T Cell Epitopes in Autoimmune Thyroid Disease

AU - Nagy, E.

AU - Morris, John C.

AU - Burch, Henry B.

AU - Bhatia, Sudershan

AU - Salata, Kalman

AU - Burman, Kenneth D.

PY - 1995/5

Y1 - 1995/5

N2 - The human TSH receptor represents the primary target of thyroid-stimulating immunoglobulins responsible for the hyperthyroidism of Graves' disease. In the present series of investigations, the distribution of T cell epitopes has been mapped using synthetic peptides spanning the entire extracellular region of the human TSH receptor. In vitro proliferatire responses of the mononuclear cells were measured using flow cytometric analysis of bromodeoxyuridine incorporation into nuclei. In 8 of 11 samples from patients with Graves' disease, at least one (and up to 9) regions of the human TSH receptor induced proliferation, with the mean stimulation index being 39.8 ± 47.3. No single universal stimulatory peptide was identified. In contrast, stimulation was not observed in three control subjects, while one control subject showed minimal stimulation (index of 5.7) to peptides encompassing a limited area (amino acids 31-65). The immunodominant epitope of patients with recent-onset Graves' disease was localized between amino acids 271 and 365, whereas the immunodominant epitope of patients with disease duration greater than 1 year localized between amino acids 91 and 215. We conclude that the bromodeoxyuridine incorporation method is a useful and important tool for detecting antigen-induced lymphocyte proliferation. The TSH receptor-specific T cells from different Graves' disease patients recognize variable distinct sites within the extracellular region of the TSH receptor, and the immunodominant epitope apparently shifts toward the N-terminus of the receptor protein during the course of treated Graves' disease.

AB - The human TSH receptor represents the primary target of thyroid-stimulating immunoglobulins responsible for the hyperthyroidism of Graves' disease. In the present series of investigations, the distribution of T cell epitopes has been mapped using synthetic peptides spanning the entire extracellular region of the human TSH receptor. In vitro proliferatire responses of the mononuclear cells were measured using flow cytometric analysis of bromodeoxyuridine incorporation into nuclei. In 8 of 11 samples from patients with Graves' disease, at least one (and up to 9) regions of the human TSH receptor induced proliferation, with the mean stimulation index being 39.8 ± 47.3. No single universal stimulatory peptide was identified. In contrast, stimulation was not observed in three control subjects, while one control subject showed minimal stimulation (index of 5.7) to peptides encompassing a limited area (amino acids 31-65). The immunodominant epitope of patients with recent-onset Graves' disease was localized between amino acids 271 and 365, whereas the immunodominant epitope of patients with disease duration greater than 1 year localized between amino acids 91 and 215. We conclude that the bromodeoxyuridine incorporation method is a useful and important tool for detecting antigen-induced lymphocyte proliferation. The TSH receptor-specific T cells from different Graves' disease patients recognize variable distinct sites within the extracellular region of the TSH receptor, and the immunodominant epitope apparently shifts toward the N-terminus of the receptor protein during the course of treated Graves' disease.

UR - http://www.scopus.com/inward/record.url?scp=0028985922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028985922&partnerID=8YFLogxK

U2 - 10.1006/clin.1995.1060

DO - 10.1006/clin.1995.1060

M3 - Article

C2 - 7535671

AN - SCOPUS:0028985922

VL - 75

SP - 117

EP - 124

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -